Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeigler-Johnson, C. M.
Right arrow Articles by Kuller, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeigler-Johnson, C. M.
Right arrow Articles by Kuller, L. H.

(Stroke. 1998;29:759-764.)
© 1998 American Heart Association, Inc.


Original Contributions

Subclinical Atherosclerosis in Relation to Hysterectomy Status in Black Women

Charnita M. Zeigler-Johnson, MPH; Janice L. Holmes, PhD; Holly C. Lassila, DrPH; Kim Sutton-Tyrrell, DrPH; Lewis H. Kuller, MD, DrPH

From the Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh (Pa) (C.M.Z.-J., H.C.L., K.S.-T., L.H.K.), and the Department of Nursing and Allied Health Professions, College of Health and Human Services, Indiana University of Pennsylvania (J.L.H.), Indiana, Pa.

Correspondence to Charnita M. Zeigler-Johnson, Department of Epidemiology, 127 Parran Hall, Graduate School of Public Health, University of Pittsburgh, 130 DeSoto St, Pittsburgh, PA 15261. E-mail CMZST2{at}cis.vms.pitt.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background and Purpose—This study was designed to investigate whether black women who underwent hysterectomy only (n=59) or hysterectomy plus bilateral oophorectomy (n=25) were at increased risk of subclinical carotid atherosclerosis compared with black women who underwent natural menopause (n=54). The effects of both surgery and menopausal status were evaluated.

Methods—Women aged 34 to 58 years were recruited from the Pittsburgh, Pa, area. Postmenopausal status was defined as a serum follicle-stimulating hormone level of >30 mIU/mL. Carotid duplex scans were performed to assess the degree of focal plaque.

Results—Among premenopausal women, focal plaque was present in 20% of nonhysterectomized versus 49% of hysterectomized-only women (P=.004). Among postmenopausal women, plaque was present in 69% of nonhysterectomized women, 86% of women with hysterectomy only, and 48% of women with oophorectomy and hysterectomy (P=.056). Among postmenopausal women, hormone replacement therapy was used by 23% of women who had undergone natural menopause, 0% of women with hysterectomy only, and 36% of women with oophorectomy and hysterectomy. The prevalence of plaque was 33% among hormone replacement therapy users versus 73% among nonusers (P=.014). In multivariate analysis, independent associations with the presence of at least 1 plaque were postmenopausal status and hysterectomy only.

Conclusions—These data suggest that black women who undergo hysterectomy without oophorectomy may be at higher risk of subclinical carotid atherosclerosis than black women who undergo natural menopause or hysterectomy plus oophorectomy.


Key Words: atherosclerosis • blacks • carotid arteries • hormones • ultrasonography, Doppler


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowSubjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Heart disease and stroke are among the leading causes of morbidity and mortality for women who live in industrialized nations.1 In the United States, morbidity and mortality rates for myocardial infarction and stroke in women younger than 60 years are significantly greater for black women than for white women.2 3 4 5 Black women also have an increased prevalence of hypertension, diabetes, and obesity, common cardiovascular risk factors.6 7 8 9 10 11 12 13 14 These same factors have been found to be independently associated with leiomyomas (uterine fibroids),9 14 the primary reason for hysterectomy in black women.15

Removal of the uterus alone or in combination with oophorectomy is believed to result in an increased risk of cardiovascular events.16 17 18 19 It has been suggested that the rates of hysterectomy are higher for black women than for white women,20 21 although the data are inconsistent.15 22 23 In Pittsburgh, Pa, the prevalence rate for hysterectomy in black women (47%) is almost twice that in white women (24%).20 21 Data from 16 states indicate that overall rates for hysterectomy are approximately 23% for white women and 22% for black women. The prevalence rates of leiomyomas necessitating hysterectomy are consistently higher in black women.15 20 24

Variation in hysterectomy rates among black and white women may be related to access to health care and health insurance and the prevalence of disease associated with need for hysterectomy. There is substantial variation in hysterectomy rates by state.22

The high prevalence rate of hysterectomy related to uterine fibroids in black women younger than 60 years potentially may be associated with an increased risk of cardiovascular disease. Few studies have examined the risk of cardiovascular disease after hysterectomy, especially among black women. Subclinical cardiovascular disease can be identified by ultrasound techniques used to determine subclinical carotid artery disease.25 The carotid arteries have been used in research, because they are easily accessible through noninvasive ultrasound techniques. The purpose of this study was to assess cardiovascular disease risk through evaluation of subclinical carotid atherosclerosis in 138 black women aged 34 to 58 years and living in Pittsburgh, Pa. We compared the prevalence of subclinical disease between women who underwent hysterectomy with or without oophorectomy and those who experienced natural menopause.


*    Subjects and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Subjects and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
The Heart, Osteoporosis, Postmenopausal Estrogen (HOPE) Study was designed to determine the risk factors related to hysterectomy in black women. Hysterectomized women were patients at Magee Women's Hospital (Pittsburgh, Pa) who had been hysterectomized with or without bilateral oophorectomy. Patients were excluded from the study if hysterectomy occurred after age 45 or if there was a personal history of gynecological cancer. Nonhysterectomized women were randomly selected (via block sampling) from a list of 1000 females on the voter registration list for Allegheny County, Pennsylvania. Initial screening was done via a telephone interview with each participant.

All participants were evaluated between 1992 and 1994 at the University of Pittsburgh. This evaluation included anthropometric measures and blood analysis for determination of lipid, glucose, and follicle-stimulating hormone (FSH) levels. Postmenopausal status was defined as a serum FSH level of >30 mIU/mL.26

From 1995 to 1996, HOPE participants were invited by letter and telephone contact to undergo a carotid ultrasound evaluation. Of 287 eligible women, 49 (17%) were lost to follow-up and 87 (30%) refused, leaving 151 women who were studied successfully. Three of the women in the final sample were excluded because their menopausal status could not be confirmed by the FSH assay, and 5 oophorectomized women were excluded because their FSH levels were below those defined as postmenopausal. Four women were excluded because of missing data and 1 because she was unilaterally oophorectomized. The final sample (n=138) consisted of 54 control subjects, 59 women with hysterectomy only, and 25 women with hysterectomy and bilateral oophorectomy. All participants signed informed consent forms approved by the Institutional Review Board of the University of Pittsburgh.

Duplex scanning was performed at the University of Pittsburgh Ultrasound Research Laboratory with a Toshiba SSA-270A scanner (Toshiba American Medical Systems). The participant was placed in a supine position, with the head tilted at a 45° angle. The probe was first positioned to obtain a cross-sectional overview of the carotid artery. More detailed longitudinal pictures were then obtained of the distal common carotid, the carotid bulb, and the internal carotid arteries for evaluation of each area from a number of projections.

Video images were evaluated for the number and size of focal plaques. Plaque was defined as a focal protrusion into the lumen vessel or an echogenic focal area seen on any wall of the artery. The carotid system was divided into five segments. For each segment, the degree of plaque was graded from 0 (no observable plaque) to 3 (plaque covering 50% of the vessel diameter). The presence of carotid artery plaque was determined from these grades.27 Sonographers and readers were masked to the hysterectomy status of participants.

Statistical Analysis
Descriptive statistics were computed for all variables. Comparisons between groups were performed by the t test (or the Mann-Whitney test for variables not normally distributed) and ANOVA. Age adjustment was achieved by ANCOVA. The Pearson {chi}2 statistic was used to investigate the association between plaque and categorical variables such as hormone replacement therapy (HRT) use, smoking status, hysterectomy status, and menopausal status. Logistic regres-sion was used to determine which risk factors were related independently to the presence or absence of any carotid plaque.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
*Results
down arrowDiscussion
down arrowReferences
 
In the HOPE sample, there were 54 nonhysterectomized women, of whom 41 were premenopausal and 13 were postmenopausal. There were 59 hysterectomized-only women, of whom 45 were premenopausal and 14 were postmenopausal. All 25 oophorectomized/hysterectomized women were postmenopausal. The average age in the sample population was 49.0 years, and 25% were current smokers.

The distribution of risk factors by hysterectomy and menopausal status is shown in Tables 1Down and 2Down. Levels of apolipoprotein (apo) A-1 differed by hysterectomy status for both premenopausal and postmenopausal women. In postmenopausal women, use of HRT also varied dramatically across the groups: 23.1% for postmenopausal controls, 0% for postmenopausal hysterectomized-only women, and 36% for oophorectomized/hysterectomized women.


View this table:
[in this window]
[in a new window]
 
Table 1. Comparisons of Means Across Hysterectomy Groups for Premenopausal Women


View this table:
[in this window]
[in a new window]
 
Table 2. Comparisons of Means Across Hysterectomy Groups for Postmenopausal Women

At least 1 focal plaque was present in 46% of all participants. The prevalence of plaque was clearly associated with hysterectomy status for both premenopausal and postmenopausal women (Fig 1Down). Among premenopausal women, 19.5% of nonhysterectomized women had plaque compared with 48.9% of hysterectomized-only women (P=.004). Among postmenopausal women, plaque was present in 69.2% of nonhysterectomized women, 85.7% of hysterectomized-only women, and 48% of oophorectomized/hysterectomized women (P=.056).



View larger version (24K):
[in this window]
[in a new window]
 
Figure 1. Graph showing by group the percentage of women with at least 1 plaque (n=138). Premen indicates premenopausal; Postmen, postmenopausal; Non-Hyst, nonhysterectomy; Hyst, hysterectomy without oophorectomy; and Ooph-Hyst, oophorectomy with hysterectomy.

A number of other baseline variables were associated with focal plaque. Women with at least 1 plaque were significantly older and had significantly higher total cholesterol, LDL, apo A-2, and triglyceride levels. However, after adjusting for age, these relationships were no longer significant (Table 3Down). Current smoking was reported for 30% of women with plaque and 21% of women without plaque (P=.345).


View this table:
[in this window]
[in a new window]
 
Table 3. Age-Adjusted Comparisons of Means for HOPE Participants With and Without Plaque (n=138)

HRT use was evaluated among postmenopausal women. Thirty-three percent of HRT users had plaque compared with 72.5% of HRT nonusers (P=.014). This was despite the fact that the mean age of HRT users (50.3 years) was similar to that of nonusers (52.8 years). HRT was used by 3 of 13 nonhysterectomized women, 0 hysterectomized women, and 9 of 25 oophorectomized/hysterectomized women. Within each group, a lower percentage of HRT users than nonusers were likely to have plaque. However, because of the small numbers represented in these groups, this did not reach statistical significance.

Multivariate analyses were performed for the total HOPE sample as well as separately for premenopausal and postmenopausal women (Table 4Down). Age or menopausal status, systolic blood pressure, LDL level, smoking status, and hysterectomy status were included in the model, with HRT added to the postmenopausal model only. For the entire group, each of these variables was positively related to the presence of plaque. Results reached statistical significance for menopausal status and hysterectomy without oophorectomy. (Age also reached statistical significance, but because of the strong relationship between age and menopausal status, only one or the other could be placed in the models.) The odds of carotid plaque presence were 3.7 times greater for postmenopausal than premenopausal women. In women with hysterectomy only, the odds were 4.5 times greater than those for nonhysterectomized women. These odds were similar for both premenopausal and postmenopausal women. Among postmenopausal women, HRT nonusers appeared to have a greater prevalence of plaque than HRT users. However, because of the small numbers in the group, this did not reach statistical significance.


View this table:
[in this window]
[in a new window]
 
Table 4. Factors Associated With Prevalence of Plaque in HOPE Sample: Multivariate Models


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
*Discussion
down arrowReferences
 
The study results indicate an increase in carotid atherosclerosis among women who have undergone hysterectomy without an oophorectomy. This was especially true for premenopausal women. These findings are consistent with those in the literature reporting that hysterectomy alone is associated with an increase in cardiovascular disease risk factors.16 18 28 It has been hypothesized that the uterus may serve a hormonal or other secretory function (such as prostaglandin secretion, which may act on blood pressure or blood vessel contraction) that prevents cardiovascular disease in premenopausal women.28 It is also possible that removal of the uterus decreases blood flow to the ovaries, thus affecting their function.29 Another hypothesis is that the loss of iron during menstruation reduces oxidized LDL and subsequently impedes the progression of atherosclerosis.30 31 However, it is more likely that women who undergo hysterectomy are a select group with higher levels of cardiovascular risk factors. Uterine fibroids, the leading cause of hysterectomy in black women,15 are known to be associated with obesity and hypertension.9 14 Factors associated with susceptibility to fibroid development may also predispose women to plaque development.32 Another possibility is that the irregular menstrual cycles associated with obesity and fibroids may result in lower peripheral estrogen levels during the reproductive years and therefore increase the risk of atherosclerosis.

If lower levels of endogenous estrogens were the primary factor linking hysterectomy with increased atherosclerosis, one would expect the highest risk group to be the hysterectomized/oophorectomized group. Surprisingly, this was not the case. Among the postmenopausal women, those who had a combined hysterectomy/oophorectomy actually had the lowest levels of plaque. One limitation of the current study is that there were only 25 women in the hysterectomy/oophorectomy group. Thus, the low levels of carotid plaque found in these women may not be representative of all women in this category. Another possibility is that the primary indication for surgery differed for those with hysterectomy/oophorectomy versus hysterectomy alone. A final possibility may relate to higher endogenous and exogenous hormone levels in women with oophorectomy. Women with oophorectomy were much more likely to be HRT users, and although not significant, they also had a higher body mass index than those with hysterectomy alone. Higher levels of body fat have been associated with higher levels of circulating estrogens.33 34

Higher circulating estrogen resulting from obesity may in part account for the relatively low HRT use among black women. In the present study, 33% of women with oophorectomy were HRT users compared with 0% of the hysterectomy-only group. HRT therapy consistently has been associated with a better lipid profile as well as a reduction in cardiovascular events. In the ARIC Study,35 postmenopausal women who were current users of estrogen replacement therapy had significantly higher levels of HDL, HDL2, HDL3, and apo A-1 than did postmenopausal nonusers. They also had significantly lower levels of glucose, LDL, apo B, and lipoprotein(a) than nonusers. The Nurses' Study36 showed a significantly decreased risk of myocardial infarction for bilaterally oophorectomized women who used HRT compared with bilaterally oophorectomized nonusers. In the current study, HRT nonuse was associated with higher levels of carotid plaque. It is possible that HRT should be recommended for surgical as well as natural menopause, after individual assessment.

Although the results of this study are compelling, there are limitations to the interpretation. Weaknesses of this study include the observational design, which inhibits our ability to make conclusions regarding causality; a small sample size, which results in lack of statistical power and perhaps a unique sample of women; and possible biases. One such bias might be a compliance bias, whereby women who comply with HRT use may be more health conscious than nonusers. There also may be confounding by socioeconomic status or other risk factors that were not measured. Last, because this is a sample of black women from a distinct geographical area, the generalizability of these results to the general population is limited.

The results of this study demonstrate that there is an increased risk of subclinical carotid atherosclerosis among postmenopausal women and in premenopausal women with a history of hysterectomy. Such women have a high prevalence rate of plaque. The exact mechanism that places hysterectomized women at increased risk of atherosclerosis is not completely understood. Given the known high prevalence rate of hysterectomy among black women, especially at younger ages, the need to identify and treat these women is a public health priority if we are to reduce the increased cardiovascular morbidity and mortality within the black community.


*    Acknowledgments
 
This project was funded by an Office of Research in Women's Health supplement to grant HL50439. Research was done under the tenure of an Established Investigatorship from the American Heart Association (Dr Sutton-Tyrrell) and a National Heart, Lung, and Blood Institute minority investigator research award (Dr Holmes).

Received September 24, 1997; revision received December 9, 1997; accepted December 23, 1997.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowSubjects and Methods
up arrowResults
up arrowDiscussion
*References
 
1. Kannel WB, Wilson PWF. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med. 1995;155:57–61.[Abstract/Free Full Text]

2. Sacco RL, Hauser WA, Mohr JP. Hospitalized stroke in blacks and Hispanics in Northern Manhattan. Stroke. 1991;22:1491–1496.[Abstract/Free Full Text]

3. Sprafka JM, Folsom AR, Burke GL, Edlavitch SA. Prevalence of cardiovascular disease risk factors in blacks and whites: The Minnesota Heart Survey. Am J Public Health. 1988;78:1546–1549.[Abstract/Free Full Text]

4. Gillum RF. Stroke in blacks. Stroke. 1988; 19:1–9.

5. National Center for Health Statistics. Health United States 1995. Hyattsville, Md: Public Health Service. 1996;127:130.

6. Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation. 1993;88:1999–2009.[Free Full Text]

7. The National Heart, Lung, and Blood Institute Growth and Health Study Research Group. Obesity and cardiovascular disease risk factors in black and white girls: The NHLBI Growth and Health Study. Am J Public Health. 1992;82:1613–1620.[Abstract/Free Full Text]

8. Healthy People 2000. Washington, DC: Department of Health and Human Services; 1990:93.

9. Summers WE, Watson RL, Wooldridge WH, Langford HG. Hypertension, obesity, and fibromyomata uteri, as a syndrome. Arch Intern Med. 1971;128:750–754.[Abstract/Free Full Text]

10. Lackland DT, Keil JE. Epidemiology of hypertension in African-Americans. Semin Nephrol. 1996;16:63–70.[Medline] [Order article via Infotrieve]

11. Carter-Nolan PL, Adams-Campbell LL, Williams J. Recruitment strategies for black women at risk for noninsulin-dependent diabetes mellitus into exercise protocols: a qualitative assessment. JAMA. 1996;88:558–562.

12. Otten MW, Teutsch SM, Williamson DF, Marks JS. The effect of known risk factors on the excess mortality of black adults in the United States. JAMA. 1990;263:845–850.[Abstract/Free Full Text]

13. Curry CL. Hypertension in black women. Paper presented at Miniconsultation on the Mental and Physical Health Problems of Black Women, sponsored by the Black Women's Community Development Foundation; March 29–30, 1974; Washington, DC.

14. Shikora SA, Niloff JM, Bistrian BR, Forse RA, Blackburn GL. Relationship between obesity and uterine fibromyomata. Nutrition. 1991;7:251–255.[Medline] [Order article via Infotrieve]

15. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States. Obstet Gynecol. 1994;83:549–555.[Medline] [Order article via Infotrieve]

16. Pansini F, Bonaccorsi G, Calisesi M, Campobasso C, Franze GP, Gilli G, Locorotondo G, Mollica G. Influence of spontaneous and surgical menopause on atherogenic metabolic risk. Maturitas. 1993;17:181–190.[Medline] [Order article via Infotrieve]

17. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47–63.[Medline] [Order article via Infotrieve]

18. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. Ann Intern Med. 1978;89:157–161.

19. Punnonen R, Ikalainen M, Seppala E. Premenopausal hysterectomy and risk of cardiovascular disease. Lancet.. 1987;1:1139. Letter.

20. Meilahn EN, Matthews KA, Egeland G, Kelsey SF. Characteristics of women with hysterectomy. Maturitas. 1989;11:319–329.[Medline] [Order article via Infotrieve]

21. Wing RR, Kuller LH, Bunker C, Matthews K, Caggiula A, Meilahn E, Kelsey S. Obesity, obesity-related behaviors and coronary heart disease risk factors in black and white premenopausal women. Int J Obes. 1989;13:511–519.[Medline] [Order article via Infotrieve]

22. Kjerulff K, Langenberg P, Guzinski G. The socioeconomic correlates of hysterectomies in the United States. Public Health Briefs. 1993;83:106–108.

23. Lepine LA, Hillis SD, Marchbanks PA, Koonin LM, Morrow B, Kieke BA, Wilcox LS. Hysterectomy surveillance: United States, 1993. MMWR CDC Surveill Summ. 1997;1980:46:1–15.

24. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas: racial differences in severity, symptoms and age at diagnosis. J Reprod Med. 1996;41:483–490.

25. Kuller LH, Shemanski L, Psaty BM, Borhani NO, Gardin J, Haan MN, O'Leary DH, Savage PJ, Tell GS, Tracy R. Subclinical disease as an independent risk factor for cardiovascular disease. Circulation. 1995;92:720–726.[Abstract/Free Full Text]

26. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N Engl J Med. 1989;321:641–646.[Abstract]

27. Sutton-Tyrrell K, Wolfson SK, Thompson T, Kelsey SF. Measurement variability of duplex scan assessment of carotid atherosclerosis. Stroke. 1992;23:215–220.[Abstract/Free Full Text]

28. Centerwall BS. Premenopausal hysterectomy and cardiovascular disease. Am J Obstet Gynecol. 1981;139:58–61.[Medline] [Order article via Infotrieve]

29. Chalmers C. Does hysterectomy in a premenopausal woman affect ovarian function? Med Hypotheses. 1996;46:573–575.[Medline] [Order article via Infotrieve]

30. Meyers DG. Does iron cause atherosclerosis? Kans Med. Winter 1995:178–179.

31. Sempos CT, Looker AC, Gillum RF. Iron and heart disease: the epidemiologic data. Nutr Rev. 1996;54:73–84.[Medline] [Order article via Infotrieve]

32. Moss NS, Benditt EP. Human atherosclerotic plaque cells and leiomyoma cells. Am J Pathol. 1975;78:175–190.[Abstract]

33. Edman CD, MacDonald PC. Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol. 1978;130:456.[Medline] [Order article via Infotrieve]

34. Hershcopf RJ, Bradlow HL. Obesity, diet, endogenous estrogens, and the risk of hormone-sensitive cancer. Am J Clin Nutr. 1987;45:283–289.[Abstract/Free Full Text]

35. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med. 1993;328:1069–1075.[Abstract/Free Full Text]

36. Bain C, Willett W, Hennekens CH, Rosner B, Belanger C, Speizer FE. Use of postmenopausal hormones and risk of myocardial infarction. Circulation. 1981;64:42–45.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
K. M. Dwyer, C. K. Nordstrom, C. N. Bairey Merz, and J. H. Dwyer
Carotid Wall Thickness and Years Since Bilateral Oophorectomy: The Los Angeles Atherosclerosis Study
Am. J. Epidemiol., September 1, 2002; 156(5): 438 - 444.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
O. Fustinoni and J. Biller
Ethnicity and Stroke : Beware of the Fallacies
Stroke, May 1, 2000; 31(5): 1013 - 1015.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeigler-Johnson, C. M.
Right arrow Articles by Kuller, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeigler-Johnson, C. M.
Right arrow Articles by Kuller, L. H.